The Emergence Of Certain Key Themes In The Biotechnology Market Is Expected To Drive Biotechnology Market Till 2025: Grand View Research, Inc.
The
global biotechnology market is expected to reach USD
727.1 billion by 2025, according to a new report by Grand View Research, Inc.
The emergence of certain key themes in the biotechnology market is expected to
drive growth in this industry to a lucrative extent.
These
key themes include regenerative medicine and genetics in diagnostics. Presence
of a plethora of companies focusing on the development of regenerative
therapies is anticipated to drive sector growth through to 2025. Technological
advancements pertaining to the penetration of artificial intelligence in this
industry is expected to fuel progress with potential avenues. The companies are
engaged in unleashing machine learning in order to understand individual cancer
cases, while recommending clinical trials.
Supportive
government (and its allied agencies) policies related to synthetic biology is a
major growth impacting driver in this sector. Developed economies such as UK
and the U.S. are critically monitoring and funding synthetic biology R&D
initiatives. For example, in 2010, a six months’ review of synthetic biology
headed by a panel of expert scientists was enforced by the U.S. President and
subsequently conducted a hearing of the Energy and Commerce Committee
exclusively concerning synthetic biology.
Browse full research report on Biotechnology
Market: http://www.grandviewresearch.com/industry-analysis/biotechnology-market
Further
Key Findings From the Study Suggest:
- Owing to technological advancements and
widespread application of this field in various aspects of healthcare, the
health segment is expected to exhibit strong progress in the forecast
period
- Continuous introduction of new biotechnological
products to cater to healthcare entities that are involved in diagnosis,
prognosis and biopharmaceutical development is estimated to propel the
market
- Decreasing costs and rise in number of services
in this segment are expected to drive segment with lucrative avenues
- North American pharmaceutical and biotech
companies have experienced great success in the recent years resulting in
larger share
- Introduction of technologically advanced
products and presence of various biotechnology based programs such as the
UC Davis Biotechnology Program, the University of California Biotechnology
Research and Education Program are attributive to drive the growth of sector
in the coming years
- Asia Pacific market is anticipated to grow at
the most lucrative pace due to changing health care infrastructure in this
region which drives the demand for these products
- Strong governmental support and recruitment of
highly trained Chinese scientists with the support of their administration
has made it possible for China to speedily build up capacity in area of
regenerative medicine
- Key players operating include Gilead, Celgene,
Abbott, Novo Nordisk A/S,Novartis AG, Sanofi Aventis, and Lonza
Access
Press Release By Grand View Research: http://www.grandviewresearch.com/press-release/global-biotechnology-market
About
Grand View Research, Inc:
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and
headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, the company offers market intelligence
studies ensuring relevant and fact-based research across a range of industries
including technology, chemicals, materials, healthcare and energy.
Comments
Post a Comment